Evidence map›Paper›PMID 37957275›Full record

ArticleNature biomedical engineering2023

Detection of cellular traction forces via the force-triggered Cas12a-mediated catalytic cleavage of a fluorogenic reporter strand.

Yuxin Duan, Fania Szlam, Yuesong Hu, Wenchun Chen, Renhao Li, Yonggang Ke, Roman Sniecinski, Khalid Salaita

Open access · greenAbstract read
In one paragraph

Article in Nature biomedical engineering, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Molecular Force Sensors for Biological Application.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. DNA Nanotechnology for Investigating Mechanical Signaling in the Immune System.Angewandte Chemie (International ed. in English) · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Yuxin DuanDepartment of Chemistry, Emory University, Atlanta, GA, USA.
Fania SzlamDepartment of Anesthesiology, School of Medicine, Emory University, Atlanta, GA, USA.ORCID 0000-0002-2314-9428
Yuesong HuDepartment of Chemistry, Emory University, Atlanta, GA, USA.
Wenchun ChenAflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Departments of Pediatrics, School of Medicine, Emory University, Atlanta, GA, USA.
Renhao LiAflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Departments of Pediatrics, School of Medicine, Emory University, Atlanta, GA, USA.ORCID 0000-0002-5806-5080
Yonggang KeWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University, Atlanta, GA, USA.ORCID 0000-0003-1673-2153
Roman SniecinskiDepartment of Anesthesiology, School of Medicine, Emory University, Atlanta, GA, USA. rsnieci@emory.edu.ORCID 0000-0003-4766-3314
Khalid SalaitaDepartment of Chemistry, Emory University, Atlanta, GA, USA. k.salaita@emory.edu.ORCID 0000-0003-4138-3477
Emory University · USGeorgia Institute of Technology · US

Funding

Equipment Supplement: Cell sorting flow cytometry to support the BTDDRM1GM145394 · NIGMS · EMORY UNIVERSITY · PI Khalid S. Salaita · 2023 to 2026
$5.6M
Molecular imaging technologies for mechanobiologyR01GM131099 · NIGMS · EMORY UNIVERSITY · PI MATTHEYSES, ALEXA LYNN, SALAITA, KHALID S. · 2019 to 2022
$1.6M
Mechano-ID for tagging immune cellsR01AI172452 · NIAID · EMORY UNIVERSITY · PI Khalid S. Salaita · 2023 to 2026
$1.4M
American Heart Association (American Heart Association, Inc.) 23POST1028975National Science Foundation (NSF) DMR 1905947NIAID NIH HHS R01 AI172452NIGMS NIH HHS R01 GM131099NIGMS NIH HHS RM1 GM145394U.S. Department of Health & Human Services | National Institutes of Health (NIH) RM1GM145394U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) 5R01GM131099-04
6 · The paper itself

Abstract

Molecular forces generated by cell receptors are infrequent and transient, and hence difficult to detect. Here we report an assay that leverages the CRISPR-associated protein 12a (Cas12a) to amplify the detection of cellular traction forces generated by as few as 50 adherent cells. The assay involves the immobilization of a DNA duplex modified with a ligand specific for a cell receptor. Traction forces of tens of piconewtons trigger the dehybridization of the duplex, exposing a cryptic Cas12-activating strand that sets off the indiscriminate Cas12-mediated cleavage of a fluorogenic reporter strand. We used the assay to perform hundreds of force measurements using human platelets from a single blood draw to extract individualized dose-response curves and half-maximal inhibitory concentrations for a panel of antiplatelet drugs. For seven patients who had undergone cardiopulmonary bypass, platelet dysfunction strongly correlated with the need for platelet transfusion to limit bleeding. The Cas12a-mediated detection of cellular traction forces may be used to assess cell state, and to screen for genes, cell-adhesion ligands, drugs or metabolites that modulate cell mechanics.

Indexed as

CRISPR-Cas SystemsTractionCarrier ProteinsCell AdhesionHumansProteinsCarrier ProteinsProteins

Identifiers

PMID37957275
PMCPMC11289779
OpenAlexW4388625975

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.